Date Speaker(s) Presentation Title
October 2015
Kathryn Weaver, Ph.D., M.P.H.

Kathryn Weaver, Ph.D., M.P.H.
Associate Professor, Wake Forest School of Medicine

Integrating Tobacco Cessation in the Oncology Setting
October 2015
Gwen Murphy, Ph.D., M.P.H.

Gwen Murphy, Ph.D., M.P.H.
Epidemiologist, Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics

GI Hormones and Cancer: The Good, The Bad, and The Cholecystokinin
October 2015
Dominique S. Michaud, Sc.D.

Dominique S. Michaud, Sc.D.
Professor, Tufts University Medical School

Oral Microbiome and Pancreatic Cancer
October 2015
Worta McCaskill-Stevens, M.D., M.S. & Ann M. Geiger, Ph.D., M.P.H.

Worta McCaskill-Stevens, M.D., M.S. & Ann M. Geiger, Ph.D., M.P.H.
Community Oncology and Prevention Trials Research Group & Healthcare Delivery Research Program

Opportunities in Cancer Care Delivery Research
June 2015
Martin Lajous, M.D., M.S., D.Sc.

Martin Lajous, M.D., M.S., D.Sc.
National Institute of Public Health of Mexico (INSP) (Mexico) and Center for Research and Population Health (France)

The Mexican Teachers’ Cohort: Bridging a Population Research Gap
June 2015
Mindy S. Kurzer, Ph.D.

Mindy S. Kurzer, Ph.D.
Healthy Foods, Healthy Lives Institute, University of Minnesota

Green Tea: Can It Prevent Breast Cancer?
May 2015
Jeffrey N. Weitzel, M.D.

Jeffrey N. Weitzel, M.D.
City of Hope Comprehensive Cancer Center

Translating the Genetic Epidemiology of Breast Cancer in Latinos: Genomic Tools to Address Global Disparities
May 2015
Ian Barron, Ph.D.

Ian Barron, Ph.D.
John Hopkins School of Public Health

Aspirin & Breast Cancer — Adjuvant Treatment & Mechanisms of Action
May 2015
John D. Groopman, Ph.D.

John D. Groopman, Ph.D.
Johns Hopkins Bloomberg School of Public Health

Biomarkers for Etiology and Prevention of Liver Cancer: Second Leading Cause of Global Cancer Mortality
April 2015
Kathleen Arcaro, Ph.D.

Kathleen Arcaro, Ph.D.
University of Massachusetts at Amherst

Biomarkers of Breast Cancer Risk in Breast Milk
April 2015
S. Yousuf Zafar, M.D., M.H.S.

S. Yousuf Zafar, M.D., M.H.S.
Duke Medical Oncology

The Elephant in the Room: How High Cost is Harming Cancer Care
March 2015
Brian Schmidt, M.D., Ph.D., D.D.S.

Brian Schmidt, M.D., Ph.D., D.D.S.
New York College of Dentistry

What Pain Tells Us About Cancer
February 2015
Electra Paskett, Ph.D.

Electra Paskett, Ph.D.
College of Medicine Ohio State University

Transdisciplinary Approach to Reducing Cervical Cancer in Appalachia
February 2015
Shai Silberberg, Ph.D.

Shai Silberberg, Ph.D.
National Institute of Neurological Disorders and Stroke

Enhancing the Reproducibility of Research Findings: Ongoing Activities at NIH and Beyond
December 2014
Ernest Hawk, M.D., Ph.D.

Ernest Hawk, M.D., M.P.H.
UT MD Anderson Cancer Center

Advancing Cancer Prevention & Control As Plan A: Perspectives from a Former Cancer Prevention Fellow
November 2014
Christine Friedenreich, Ph.D.

Christine Friedenreich, Ph.D.
Alberta Health Services

Epidemiologic and Biologic Evidence for the Role of Physical Activity in Cancer Risk and Survival
November 2014
Erin Costanzo, Ph.D.

Erin Costanzo, Ph.D.
Carbone Cancer Center University of Wisconsin

BioBehavioral Influences on Recovery Following Hematopoietic Stem Cell Transplantation
October 2014
Erika A. Waters, Ph.D., M.P.H.

Erika A. Waters, Ph.D., M.P.H.
Washington University School of Medicine

Translating epidemiological research for public consumption: Challenges and opportunities in communicating about risk
October 2014
Tram K. Lam, Ph.D., M.P.H.

Tram K. Lam, Ph.D., M.P.H.
National Cancer Institute

From Cancer Etiology to Population Health Impact: What Is the Role of Cancer Epidemiology in the Translational Research Continuum?